Project title: The role of ATRX/DAXX/H3.3 chromatin regulation in pancreatic neuroendocrine tumors
Laura Banaszynski, PhD UT Southwestern Medical Center
- Status: Active
- Year(s): 2017
- Grant Type: Investigator
- Research Type: Basic
- Primary Tumor Site: Pancreas
- Area of Inquiry: Mapping NET dependencies
This proposal seeks to understand the role of ATRX/DAXX/H3.3-mediated chromatin dysregulation in pancreatic neuroendocrine tumors. These studies will identify important mechanisms of genome regulation, potentially transforming our understanding of neuroendocrine tumors with a goal towards the development of new diagnostic markers and possible new methods of intervention.
- City: Dallas
- State: Texas
- Grant Duration: 2 years
- Awards: Petersen Investigator Award
- Sponsor: Margie & Robert E. Petersen Foundation
NETRF funds laboratory research to understand the development of neuroendocrine tumors and translational research to explore new concepts in treatment. Research grant descriptions and research updates from NETRF are not intended to serve as medical advice. It can take years for research discoveries to be fully validated and approved for patient care. Always consult your health care providers about your treatment options.